AXXENT SURFACE CONTROLLER
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $171,375 | 73 | 24 |
| 2022 | $229,696 | 155 | 90 |
| 2021 | $530,698 | 177 | 63 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $468,060 | 94 | 50.2% |
| Consulting Fee | $437,069 | 131 | 46.9% |
| Food and Beverage | $15,532 | 170 | 1.7% |
| Travel and Lodging | $11,108 | 10 | 1.2% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Phase II Study of Patients With Recurrent Glioblastoma Multiforme Treated With Maximal Safe Neurosurgical Resection and Intra-Operative Radiation Therapy (IORT) Using the Xoft Axxent Electronic Brachytherapy System and Bevacizumab | iCAD, Inc | $468,060 | 7 |
Top Doctors Receiving Payments for AXXENT SURFACE CONTROLLER
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $249,702 | 57 |
| , MD PHD | Neurology | Santa Monica, CA | $184,500 | 16 |
| , M.D | Specialist | Denver, CO | $170,253 | 21 |
| , M.D | Dermatology | Chula Vista, CA | $35,500 | 2 |
| , M.D | Diagnostic Radiology | New York, NY | $33,750 | 9 |
| , MD | Diagnostic Radiology | Wyoming, MI | $31,641 | 33 |
| , MD | Diagnostic Radiology | Philadelphia, PA | $30,284 | 7 |
| , M.D | Surgical Oncology | Dallas, TX | $20,539 | 10 |
| , MD | Surgery | Dallas, TX | $20,539 | 10 |
| , M.D | Surgery | Barrington, IL | $20,375 | 9 |
| , MD | Specialist | Goodlettsville, TN | $20,375 | 9 |
| , M.D | Surgery | Stuart, FL | $18,705 | 7 |
| , MD | Diagnostic Radiology | Rochester, NY | $15,000 | 2 |
| , M.D | Diagnostic Radiology | Muncie, IN | $14,457 | 11 |
| , MD | Specialist | Flint, MI | $13,213 | 12 |
| , M.D | Orthopaedic Surgery | Plano, TX | $11,247 | 7 |
| , M.D | Specialist | Oceanside, CA | $8,150 | 1 |
| , M.D | Therapeutic Radiology | Orlando, FL | $5,000 | 1 |
| , MD | Radiation Oncology | Atlanta, GA | $3,250 | 6 |
| , MD | Radiation Oncology | Pittsburgh, PA | $3,000 | 3 |
| , M.D | Dermatology | Los Angeles, CA | $2,764 | 5 |
| , MD | Hematology & Oncology | Atlanta, GA | $2,000 | 2 |
| , MD | Dermatology | Pasadena, CA | $1,776 | 3 |
| , M.D | Radiation Oncology | Oklahoma City, OK | $1,646 | 2 |
| , MD | Specialist | Westlake Village, CA | $1,646 | 2 |
About AXXENT SURFACE CONTROLLER
AXXENT SURFACE CONTROLLER is a device associated with $931,769 in payments to 154 healthcare providers, recorded across 405 transactions in the CMS Open Payments database. The primary manufacturer is iCAD, Inc.
Payment data is available from 2021 to 2023. In 2023, $171,375 was paid across 73 transactions to 24 doctors.
The most common payment nature for AXXENT SURFACE CONTROLLER is "Unspecified" ($468,060, 50.2% of total).
AXXENT SURFACE CONTROLLER is associated with 1 research study, including "Phase II Study of Patients With Recurrent Glioblastoma Multiforme Treated With Maximal Safe Neurosurgical Resection and Intra-Operative Radiation Therapy (IORT) Using the Xoft Axxent Electronic Brachytherapy System and Bevacizumab" ($468,060).